SCHEMBL3426883

SCHEMBL3426883

CC(=O)Nc1nc(-c2nc[nH]n2)c2ccc(Br)cc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 3/20 0.43
POLB P06746 1/20 0.40
CYP1A2 P05177 2/20 0.38
NPC1 O15118 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
CLK1 P49759 2/20 0.37
ADORA3 P0DMS8 1/20 0.36
MAPT P10636 4/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
APP P05067 2/20 0.35
ACHE P22303 2/20 0.35
THRB P10828 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
IDO1 P14902 1/20 0.34
EGFR P00533 2/20 0.34
PTGFR P43088 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3338169 0.91 POLB (0.50) DYRK1APOLBCYP1A2NPC1CYP3A4
SCHEMBL3337363 0.76 ADORA3 (0.40) CYP1A2CYP3A4CYP2C19RAB9AADORA3
SCHEMBL3336353 0.75 ACHE (0.47) DYRK1AADORA3APPACHE
SCHEMBL4526080 0.70 GAK (0.48) DYRK1AADORA3
SCHEMBL4528265 0.70 ADORA3 (0.47) POLBNPC1CYP2C19RAB9AADORA3
SCHEMBL3924803 0.70 MAPK14 (0.39) DYRK1APOLBADORA3
SCHEMBL4108181 0.70 ADORA3 (0.41) CYP1A2NPC1RAB9AADORA3APP
SCHEMBL3920025 0.69 ABL1 (0.42) DYRK1APOLBADORA3
SCHEMBL3931835 0.69 ADORA3 (0.41) POLBNPC1RAB9AADORA3
SCHEMBL4066924 0.69 DYRK1B (0.36) DYRK1APOLBMAPTCDK5RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010146173-A1 QUINAZOLINE DERIVATIVES AS HISTAMINE H4-RECEPT0R INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG (NL) 2010-12-23 WO disclosed